What are the Treatment Options for Pediatric Hepatitis C?
Recent advances in antiviral therapy have dramatically improved the treatment of hepatitis C in children. Direct-acting antivirals (DAAs) are now recommended for children aged 3 years and older. Treatment regimens are typically well-tolerated and have high cure rates. The choice of therapy depends on various factors, including the child's age, genotype of the virus, and liver disease stage.
